Endostatin/collagen XVIII accumulates in patients with traumatic brain injury

Journal of Neurotrauma

Volumn 23, Issue 7, 2006, Pages 1103-1110

  Deininger, Martin H ^a   Meyermann, Richard ^b   Schluesener, Hermann J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Endostatin collagen XVIII; NO signaling cascade; Traumatic brain injury

Indexed keywords

AMINOGUANIDINE; COLLAGEN TYPE 18; ENDOSTATIN; HYDROGEN PEROXIDE; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; VASCULOTROPIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN HYPOXIA; BRAIN PERFUSION; CAUSE OF DEATH; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MOUSE; NERVE CELL LESION; NONHUMAN; OXIDATIVE STRESS; STATISTICAL ANALYSIS; SURVIVAL TIME; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; BRAIN INJURIES; CELLS, CULTURED; COLLAGEN TYPE XVIII; ENDOSTATINS; FEMALE; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICROGLIA; MIDDLE AGED;

EID: 33746719298     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.1103     Document Type: Article

References (30)

1. BESCHORNER, R., ADJODAH, D., SCHWAB, J.M., et al. (2000). Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol. 100, 377-384.
2. BOEHM, T., FOLKMAN, J., BROWDER, T., et al. (1997). Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-407.
3. CHANDEL, N.S., MALTEPE, E., GOLDWASSER, E., et al. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. U.S.A. 95, 11715-11720.
4. 2 in rat heart endothelial cells. Free Radic. Biol. Med. 25, 891-897.
5. DHANABAL, M., RAMCHANDRAN, R., WATERMAN, M.J., et al. (1999). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
6. DIXELIUS, J., LARSSON, H., SASAKI, T., et al. (2000). Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95, 3403-3411.
7. FEELISCH, M. (1998). The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch. Pharmacol. 358, 113-122.
8. FERRARI, D., VILLALBA, M., CHIOZZI, P., et al. (1996). Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156, 1531-1539.
9. HALL, E.D., KUPINA, N.C., and ALTHAUS, J.S. (1999). Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann. N.Y. Acad. Sci. 890, 462-468.
10. KUROKI, M., VOEST, E.E., AMANO, S., et al. (1996). Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98, 1667-1675.
11. MATES, J.M., and SANCHEZ-JIMENEZ, F.M. (2000). Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell. Biol. 32, 157-170.
12. MCGRAW, J., HIEBERT, G.W., and STEEVES, J.D. (2001). Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63, 109-115.
13. MILLER, M.J., THOMPSON, J.H., LIU, X., et al. (1996). Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase. Inflamm. Res. 45, 272-276.
14. MIOSGE, N., SASAKI, T., and TIMPL, R. (1999). Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J. 13, 1743-1750.
15. MONCADA, S., and HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012.
16. MOULTON, K.S., HELLER, E., KONERDING, M.A., et al. (1999). Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99, 1726-1732.
17. NAG, S., TAKAHASHI, J.L., and KILTY, D.W. (1997). Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56, 912-921.
18. NAG, S., ESKANDARIAN, M.R., DAVIS, J., et al. (2002). Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury. Neuropathol. Exp. Neurol. 61, 778-788.
19. NILSSON, B.O. (1999). Biological effects of aminoguanidine: an update. Inflamm. Res. 48, 509-515.
20. O'REILLY, M.S., BOEHM, T., SHING, Y., et al. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
21. PAPAVASSILIOU, E., GOGATE, N., PROESCHOLDT, M., et al. (1997). Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 49, 451-460.
22. SCHLUESENER, H.J., SEID, K., ZHAO, Y., and MEYERMANN, R. (1997). Localization of endotheliaL-monocyte-activating polypetide II (EMAO II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia 20, 365-372.
23. SHICHIRI, M., and HIRATA, Y. (2001). Antiangiogenesis signals by endostatin. FASEB J. 15, 1044-1053.
24. STANDKER, L., SCHRADER, M., KANSE, S.M., et al. (1997). Isolation and characterization of the circulating form of human endostatin. FEES Lett. 420, 129-133.
25. STRIK, H.M., SCHLUESENER, H.J., SEID, K., et al. (2001). Localization of endostatin in rat and human gliomas. Cancer 91, 1013-1019.
26. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
27. TETSUKA, T., and MORRISON, A.R. (1995). Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1 beta. Am. J. Physiol. 269, C55-C59.
28. TUDER, R.M., FLOOK, B.E., and VOELKEL, N.F. (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95, 1798-1807.
29. URBICH, C., REISSNER, A., CHAVAKIS, E., et al. (2002). Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J. 16, 706-708.
30. YAMAGUCHI, N., ANAND-APTE, B., LEE, M., et al. (1999). Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18, 4414-4423.